Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Prostate Cancer Diagnostic Algorithm as a "Road Map" from the First Stratification of the Patient to the Final Treatment Decision

H. Sedláčková, O. Dolejšová, M. Hora, J. Ferda, O. Hes, O. Topolčan, R. Fuchsová, R. Kučera

. 2021 ; 11 (4) : . [pub] 20210407

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018018

Grantová podpora
CZ.02.1.01/0.0/0.0/16_013/0001674. BBMRI-CZ: Biobank network - a versatile platform for the research of the etiopathogenesis of diseases
FNPl, 00669806 Ministry of Health, Czech Republic - conceptual development of research organization (Faculty Hospital in Pilsen - FNPl, 00669806)

The diagnostics of prostate cancer are currently based on three pillars: prostate biomarker panel, imaging techniques, and histological verification. This paper presents a diagnostic algorithm that can serve as a "road map": from initial patient stratification to the final decision regarding treatment. The algorithm is based on a review of the current literature combined with our own experience. Diagnostic algorithms are a feature of an advanced healthcare system in which all steps are consciously coordinated and optimized to ensure the proper individualization of the treatment process. The prostate cancer diagnostic algorithm was created using the prostate specific antigen and in particular the Prostate Health Index in the first line of patient stratification. It then continued on the diagnostic pathway via imaging techniques, biopsy, or active surveillance, and then on to the treatment decision itself. In conclusion, the prostate cancer diagnostic algorithm presented here is a functional tool for initial patient stratification, comprehensive staging, and aggressiveness assessment. Above all, emphasis is placed on the use of the Prostate Health Index (PHI) in the first stratification of the patients as a predictor of aggressiveness and clinical stage of prostrate cancer (PCa). The inclusion of PHI in the algorithm significantly increases the accuracy and speed of the diagnostic procedure and allows to choose the optimal pathway just from the beginning. The use of advanced diagnostic techniques allows us to move towards to a more advanced level of cancer care. This diagnostics algorithm has become a standard of care in our hospital. The algorithm is continuously validated and modified based on our results.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018018
003      
CZ-PrNML
005      
20210729104109.0
007      
ta
008      
210726s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/life11040324 $2 doi
035    __
$a (PubMed)33917253
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sedláčková, Hana $u Department of Urology, Faculty of Medicine in Pilsen, University Hospital, 305 99 Pilsen, Czech Republic
245    10
$a Prostate Cancer Diagnostic Algorithm as a "Road Map" from the First Stratification of the Patient to the Final Treatment Decision / $c H. Sedláčková, O. Dolejšová, M. Hora, J. Ferda, O. Hes, O. Topolčan, R. Fuchsová, R. Kučera
520    9_
$a The diagnostics of prostate cancer are currently based on three pillars: prostate biomarker panel, imaging techniques, and histological verification. This paper presents a diagnostic algorithm that can serve as a "road map": from initial patient stratification to the final decision regarding treatment. The algorithm is based on a review of the current literature combined with our own experience. Diagnostic algorithms are a feature of an advanced healthcare system in which all steps are consciously coordinated and optimized to ensure the proper individualization of the treatment process. The prostate cancer diagnostic algorithm was created using the prostate specific antigen and in particular the Prostate Health Index in the first line of patient stratification. It then continued on the diagnostic pathway via imaging techniques, biopsy, or active surveillance, and then on to the treatment decision itself. In conclusion, the prostate cancer diagnostic algorithm presented here is a functional tool for initial patient stratification, comprehensive staging, and aggressiveness assessment. Above all, emphasis is placed on the use of the Prostate Health Index (PHI) in the first stratification of the patients as a predictor of aggressiveness and clinical stage of prostrate cancer (PCa). The inclusion of PHI in the algorithm significantly increases the accuracy and speed of the diagnostic procedure and allows to choose the optimal pathway just from the beginning. The use of advanced diagnostic techniques allows us to move towards to a more advanced level of cancer care. This diagnostics algorithm has become a standard of care in our hospital. The algorithm is continuously validated and modified based on our results.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dolejšová, Olga $u Department of Urology, Faculty of Medicine in Pilsen, University Hospital, 305 99 Pilsen, Czech Republic
700    1_
$a Hora, Milan $u Department of Urology, Faculty of Medicine in Pilsen, University Hospital, 305 99 Pilsen, Czech Republic
700    1_
$a Ferda, Jiří $u Department of Medical Imaging, Faculty of Medicine in Pilsen, University Hospital, 304 60 Pilsen, Czech Republic
700    1_
$a Hes, Ondřej $u Department of Pathology, Faculty of Medicine in Pilsen, University Hospital, 305 99 Pilsen, Czech Republic
700    1_
$a Topolčan, Ondřej $u Department of Immunochemistry Diagnostics, Faculty of Medicine in Pilsen, University Hospital, 305 99 Pilsen, Czech Republic
700    1_
$a Fuchsová, Radka $u Department of Immunochemistry Diagnostics, Faculty of Medicine in Pilsen, University Hospital, 305 99 Pilsen, Czech Republic
700    1_
$a Kučera, Radek $u Department of Immunochemistry Diagnostics, Faculty of Medicine in Pilsen, University Hospital, 305 99 Pilsen, Czech Republic $u Institute of Pharmacology and Toxicology, Medical Faculty in Pilsen, Charles University, 304 60 Pilsen, Czech Republic
773    0_
$w MED00186366 $t Life (Basel, Switzerland) $x 2075-1729 $g Roč. 11, č. 4 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33917253 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20210729104108 $b ABA008
999    __
$a ind $b bmc $g 1676500 $s 1138460
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 4 $e 20210407 $i 2075-1729 $m Life $n Life (Basel) $x MED00186366
GRA    __
$a CZ.02.1.01/0.0/0.0/16_013/0001674. $p BBMRI-CZ: Biobank network - a versatile platform for the research of the etiopathogenesis of diseases
GRA    __
$a FNPl, 00669806 $p Ministry of Health, Czech Republic - conceptual development of research organization (Faculty Hospital in Pilsen - FNPl, 00669806)
LZP    __
$a Pubmed-20210726

Najít záznam

Citační ukazatele

Možnosti archivace